Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TNA vs GSK✓SelectedUSD · GSKTNA vs GSK performance historyLatest closeAs of-6.63%11/19
Stock and ETF performance explorer

TNA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.8%
GSK return
+97.7%
Excess return
-89.8%
Maximum drawdown
-88.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.6%-1.6%-5.1%-5.2%
7D-15.0%-4.7%-10.3%-11.0%
30D-14.2%-4.7%-9.5%-10.3%
3M-35.7%-8.8%-27.0%-30.6%
6M-16.6%-4.6%-11.9%-14.9%
YTD+5.4%+1.0%+4.4%-0.1%
1Y+22.0%+6.9%+15.1%+9.5%
3Y+73.9%+52.5%+21.3%-6.0%
5Y-49.4%+40.3%-89.7%-71.2%
All+7.8%+97.7%-89.8%-50.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling